{"SPADE_UN_15525": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_15525", "Peptide Name": "LysAB2 P3", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "NPEKALEKLIAIQKAIKGMLNGWFTGVGFRRKR", "Sequence Length": 33, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Tumor cells:A549 (Not active up to 200 µm)", "Hemolytic Activity": "Human erythrocytes:1.97% Hemolysis=4µM; <10% Hemolysis=256µM", "Cytotoxicity": "HaCat:Not active up to 200 µM", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C172H285N51O42S", "Mass": 3771.48, "PI": 11.12, "Net Charge": 6, "Hydrophobicity": -0.4, "Half Life": "Mammalian:1.4 hourYeast:3 minE.coli:>10 hour", "Literature": [{"Title": "Highly potent antimicrobial modified peptides derived from the Acinetobacter baumannii phage endolysin LysAB2", "Pubmed ID": "28904355", "Reference": "Sci Rep. 2017 Sep 13;7(1)11477.", "Author": "Peng SY, You RI, Lai MJ, Lin NT, Chen LK, Chang KC.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=28904355"}], "Frequent Amino Acids": "KGA", "Absent Amino Acids": "CDHOSUY", "Basic Residues": 8, "Acidic Residues": 2, "Hydrophobic Residues": 15, "Polar Residues": 16, "Positive Residues": 8, "Negative Residues": 2, "Similar Sequences": [{"SPADE_ID": "SPADE_N_11871", "Similarity": 1.0, "Sequence": "EKALEKLIAIQKAIKGMLNGWFTGVGFRRKR"}, {"SPADE_ID": "SPADE_UN_19441", "Similarity": 1.0, "Sequence": "EKALEKLIAIQKAIKGMLNGWFTGVGFRRKR"}, {"SPADE_ID": "SPADE_N_11870", "Similarity": 0.9393939393939394, "Sequence": "NPEKALEPLIAIQIAIKGMLNGWFTGVGFRRKR"}]}}}